[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335821-105":59,"doc-detail-335821-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","tetrahydrocurcumin-targets-trip13-inhibiting-the-interaction-of-trip13usp7c-flip-to-mediate-c-flip-ubiquitination-in-triple-negative-breast-cancer","Tetrahydrocurcumin targets TRIP13 - inhibiting the interaction of TRIP13/USP7/c-FLIP to mediate c-FLIP ubiquitination in triple-negative breast cancer","","Triple-negative breast cancer (TNBC) has high mortality and limited therapeutic options, while tetrahydrocurcumin (THC), a major metabolite of curcumin, shows potential antitumor activity whose mechanism in TNBC remains unclear. This study investigates THC’s action by targeting TRIP13 to disrupt the TRIP13/USP7/c-FLIP complex and promote c-FLIP ubiquitination, evaluating effects both in vitro and in vivo. Apoptosis assays and complementary target-identification and interaction studies support THC-induced extrinsic apoptosis via c-FLIP degradation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/tetrahydrocurcumin-targets-trip13-inhibiting-the-interaction-of-trip13usp7c-flip-to-mediate-c-flip-ubiquitination-in-triple-negative-breast-cancer/335821/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/tetrahydrocurcumin-targets-trip13-inhibiting-the-interaction-of-trip13usp7c-flip-to-mediate-c-flip-ubiquitination-in-triple-negative-breast-cancer/335821.png","ImageObject",300,407,{"name":92,"@type":93},"Ophelia","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main therapeutic focus of the study in TNBC?","Question",{"text":112,"@type":113},"The study focuses on tetrahydrocurcumin (THC) and its mechanism against triple-negative breast cancer (TNBC) by targeting TRIP13.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does THC induce apoptosis in TNBC?",{"text":117,"@type":113},"THC primarily induces extrinsic apoptosis by promoting the degradation of c-FLIP, a key negative regulator in the apoptotic pathway.",{"name":119,"@type":110,"acceptedAnswer":120},"What molecular interaction does THC disrupt, and what is the downstream effect?",{"text":121,"@type":113},"THC specifically targets TRIP13 to disrupt the interaction among TRIP13/USP7/c-FLIP, leading to ubiquitination of c-FLIP and ultimately promoting extrinsic apoptosis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335821,1790196555,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},7971461741311,"https://ap-avatar.wpscdn.com/avatar/74000253aff267980c6?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779345379180704826","Journal of Advanced Research 75 (2025) 591–605  \nContents lists available at ScienceDirect  \nJournal of Advanced Research  \njournal [homepage: www. elsevier. com/locate/jare](homepage: www. elsevier. com/locate/jare)  \n| Original Manuscript |  |  |\n| --- | --- | --- |\n| Tetrahydrocurcumin targets TRIP13 inhibiting the interaction of TRIP13/ USP7/c-FLIP to mediate c-FLIP ubiquitination in triple-negative breast |  | |\n| cancer\u003Cbr>Yu-jie Sun a,b, 1, Qiang Zhang a,b, ⇑, 1, Shi-jie Cao b,c, Xiao-hu Sun d, Ji-chao Zhang b,c,e, Bing-yang Zhang b,c,e, Ze-bin Shang a, Chong-yan Zhao b,c,e, Zhi-yong Cao a,b, Qiu-ju Zhang a,b, Xiu-mei Gaob, Feng Qiub,c,e, ⇑⇑, Ning Kang a,b, ⇑⇑⇑\u003Cbr>a School of Medical Technology, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, PR China\u003Cbr>b State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, PR China\u003Cbr>c Tianjin Key Laboratory of Therapeutic Substance of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, PR China d Tianjin Medical University, Cancer Institute & Hospital, Tianjin 300181, PR China\u003Cbr>e School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, PR China |  |  |\n| h i g h l i g h t s\u003Cbr>Tetrahydrocurcumin (THC), the major metabolite of curcumin (CUR), signiﬁcantly inhibits TNBC in vitro and in vivo.\u003Cbr>THC induces extrinsic apoptosis in TNBC primarily by promoting degradation of c-FLIP.\u003Cbr>TRIP13 was identiﬁed as a direct target of THC in combating TNBC. TRIP13 forms a trimeric complex with USP7 and c-FLIP, which are highly expressed in TNBC.\u003Cbr>THC speciﬁcally targets TRIP13 to disrupt the interaction of TRIP13/ USP7/c-FLIP, leading to the ubiquitination of c-FLIP. | g r a p h i c a l a b s t r a c t\u003Cbr>|  |\n\na r t i c l e i n f o  \nArticle history:  \nReceived 9 August 2024  \nRevised 6 October 2024  \nAccepted 2 November 2024  \nAvailable online 5 November 2024  \nKeywords:  \nTriple-negative breast cancer (TNBC) Tetrahydrocurcumin  \nMetabolites  \nc-FLIP/TRIP13/USP7  \na b s t r a c t  \nIntroduction: Triple-negative breast cancer (TNBC) has a high mortality rate and limited treatment options. Tetrahydrocurcumin (THC), a major metabolite of curcumin, has potential antitumor activities. However, the antitumor effects and mechanism of THC in TNBC remain elusive.  \nObjectives: To investigate the mechanism of THC in combating TNBC by targeting TRIP13 to disrupt the interaction of the TRIP13/USP7/c-FLIP complex and mediate c-FLIP ubiquitination both in vitro and in vivo.  \nMethods: Apoptosis was measured by TUNEL and ﬂow cytometry. Click chemistry-based target ﬁshing, CETSA, DARTS, and SPR were used to identify direct target of THC. Protein interactions was examined using co-immunoprecipitation. The role of USP7 in THC-mediated c-FLIP ubiquitination was evaluated by in vitro deubiquitination assay. Human breast cancer clinical samples were employed to assess the  \n⇑ Corresponding author at: School of Medical Technology, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, PR China.  \n⇑⇑ Corresponding author at: State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, PR China.⇑⇑⇑ Corresponding author at: School of Medical Technology, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, PR China.  \nE-mail addresses: [zhangqiang7@hotmail.com](zhangqiang7@hotmail.com) (Q. Zhang), [fengqiu20070118@163.com](fengqiu20070118@163.com) (F. Qiu), [kangndd@163.com](kangndd@163.com) (N. Kang).  \n1 Yu-jie Sun and Qiang Zhang contributed equally to this work.  \n[https://doi.org/10.1016/j.jare.2024.11.004](https://doi.org/10.1016/j.jare.2024.11.004)  \n2090-1232/© 2024 Published by Elsevier B.V. on behalf of Cairo University.  \nThis is an open access article under the CC BY-NC-ND license ([http://creativecommons.org/licenses/by-nc-nd/4.0/","cbCaiiTKy2NF0kyO","https://ap.wps.com/l/cbCaiiTKy2NF0kyO","pdf",5065843,15,"English","# Highlights\n## THC inhibits TNBC growth\n## THC promotes extrinsic apoptosis via c-FLIP degradation\n## TRIP13 is a direct THC target\n## Disruption of TRIP13/USP7/c-FLIP interaction","[{\"question\":\"What is the main therapeutic focus of the study in TNBC?\",\"answer\":\"The study focuses on tetrahydrocurcumin (THC) and its mechanism against triple-negative breast cancer (TNBC) by targeting TRIP13.\"},{\"question\":\"How does THC induce apoptosis in TNBC?\",\"answer\":\"THC primarily induces extrinsic apoptosis by promoting the degradation of c-FLIP, a key negative regulator in the apoptotic pathway.\"},{\"question\":\"What molecular interaction does THC disrupt, and what is the downstream effect?\",\"answer\":\"THC specifically targets TRIP13 to disrupt the interaction among TRIP13/USP7/c-FLIP, leading to ubiquitination of c-FLIP and ultimately promoting extrinsic apoptosis.\"}]","Tetrahydrocurcumin targets TRIP13 - inhibiting the interaction of TRIP13/USP7/c-FLIP to mediate c-FLIP ubiquitination in triple-negative breast cancer | PDF",1790012427,38]